论文信息 - Lorlatinib beyond progression plus platinum/pemetrexed for ALK-positive non-small cell lung cancer patients: report of two cases. - 字舞流文

Lorlatinib beyond progression plus platinum/pemetrexed for ALK-positive non-small cell lung cancer patients: report of two cases.

F. Roila | V. Ludovini | B. Di Girolamo | G. Metro | G. Bellezza | S. Baglivo | R. Matocci | Angelo Bonaiti | Niccolò Metelli | M. Mandarano | Claudia Colafigli